10.4. Pain and Inflammation in Musculoskeletal Disorders
For SPS Guidance on NSAIDs (including COX IIs) monitoring in Adults in Primary Care please click here
MHRA Drug Safety Update -Â Non-steroidal anti-inflammatory drugs (NSAIDs): potential risks following prolonged use after 20 weeks of pregnancy - GOV.UK (www.gov.uk)
For MHRA Drug Safety Update Click Here
For 10. Musculoskeletal system - Guidance page Click Here
| Pack |
|---|
| 100 tablet |
| 12 tablet |
| 16 tablet |
| 24 tablet |
| 48 tablet |
| 500 tablet |
| 8 tablet |
| 84 tablet |
| 96 tablet |
| Pack |
|---|
| 100 tablet |
| 12 tablet |
| 16 tablet |
| 24 tablet |
| 250 tablet |
| 48 tablet |
| 60 tablet |
| 84 tablet |
| 90 tablet |
| 96 tablet |
| Pack |
|---|
| 100 tablet |
| 56 tablet |
| 60 tablet |
| 84 tablet |
| 90 tablet |
| Pack |
|---|
| 100 ml |
| 150 ml |
| 200 ml |
| 500 ml |
| Pack |
|---|
| 250 tablet |
| 28 tablet |
| 56 tablet |
| 84 tablet |
| Pack |
|---|
| 100 tablet |
| 28 tablet |
| 56 tablet |
| 60 tablet |
| Pack |
|---|
| 100 tablet |
| 28 tablet |
| 84 tablet |
| Pack |
|---|
| 10 tablet |
| 100 tablet |
| 14 tablet |
| 28 tablet |
| 84 tablet |
| 90 tablet |
| Pack |
|---|
| 10 suppository |
| Pack |
|---|
| 10 ampoule |
| Pack |
|---|
| 28 tablet |
| Pack |
|---|
| 20 tablet |
| 28 tablet |
| 30 tablet |
| 40 tablet |
| Pack |
|---|
| 20 tablet |
| 28 tablet |
| 30 tablet |
| 40 tablet |
| 5 tablet |
| Pack |
|---|
| 28 tablet |
| 30 tablet |
| 5 tablet |
| 7 tablet |
| Pack |
|---|
| 28 capsule |
| 500 capsule |
| 84 capsule |
| 90 capsule |
| Pack |
|---|
| 100 capsule |
| 28 capsule |
| 84 capsule |
| 90 capsule |
| Pack |
|---|
| 100 capsule |
| 500 capsule |
| 84 capsule |
| Pack |
|---|
| 100 tablet |
| 28 tablet |
| 84 tablet |
- First Line Choice
- On Formulary
- Specialist Initiation Only
- Hospital Only
- KMPT Initiation Only